Search results
Results from the WOW.Com Content Network
A recall has been ordered for a high-profile diabetes drug after producers discovered it contained alarmingly high levels of a cancer-causing impurity. Marksans Pharma Limited has recalled ...
In February 2020, the FDA found NDMA levels in some tested metformin samples that did not exceed the acceptable daily intake. [143] [144] In February 2020, Health Canada announced a recall of Apotex immediate-release metformin, [145] followed in March by recalls of Ranbaxy metformin [146] and in March by Jamp metformin. [147]
Still used as veterinary drug and as a human antihelminthic in many markets; listed on the WHO List of Essential Medicines. In humans, it was used to treat melanoma before it was withdrawn for agranulocytosis. [29] [30] [31] Levomethadyl acetate: 2003 US Cardiac arrhythmias and cardiac arrest. [2] Lorcaserin (Belviq) 2020 US Increased risk of ...
The FDA announcement followed a recall of three versions of metformin in Singapore, and the European Medicines Agency's request that manufacturers test for NDMA. [ 24 ] [ 25 ] In September 2019, N -nitrosodimethylamine was discovered in ranitidine products from a number of manufacturers, resulting in recalls.
Metformin is a medication in a class of compounds called biguanides, according to the U.S. National Library of Medicine. These medications reduce the amount of glucose the body absorbs from food ...
While it’s positive to see that there have been fewer recalls in the U.S. this year than in 2023 or 2022, it’s still concerning to see that there are 440 recall events.
A drug recall removes a prescription or over-the-counter drug from the market. Drug recalls in the United States are made by the FDA or the creators of the drug when certain criteria are met. When a drug recall is made, the drug is removed from the market and potential legal action can be taken depending on the severity of the drug recall. [1]
Metformin — a biguanide — is an oral diabetes medication that helps keep blood sugar in check by causing the liver to produce less glucose. It was approved by the FDA in 1994 for the treatment ...